Original Research
Published on 19 Nov 2024
Prognostic significance and gene co-expression network of CD16A and FGL2 in gliomas
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1447113
- 201 views
Type at least 3 characters
29,163 articles
Articles
Editorial
Published on 19 Nov 2024
Editorial: Cell death in cancer immunology
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1504738
- 140 views
Mini Review
Published on 19 Nov 2024
Pathologic diagnosis and molecular features of gastrointestinal stromal tumors: a mini-review
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1487467
- 131 views
Case Report
Accepted on 18 Nov 2024
Preoperative Diagnosis of Primary Ovarian Lymphoma: a case report and a decade of insights
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1471654
Original Research
Accepted on 18 Nov 2024
VASARI 2.0: A new updated MRI VASARI lexicon to predict grading and IDH status in brain glioma
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1449982
Original Research
Accepted on 18 Nov 2024
Life-style and metabolic factors do not affect risk for glioma: A prospective population-based study (The Cohort of Norway)
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1471733
Case Report
Accepted on 18 Nov 2024
Long-term Follow-up of Combination Therapy with Pembrolizumab and Anlotinib in Thoracic SMARCA4-deficient Undifferentiated Tumor : A Case Report and Molecular Features
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1453895
Original Research
Accepted on 18 Nov 2024
Elucidating the causal relationship between 486 genetically predicted blood metabolites and the risk of gastric cancer: A comprehensive Mendelian randomization analysis
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2024.1418283
Original Research
Accepted on 18 Nov 2024
Prognostic Significance of CNNM4 in Ovarian Cancer: A Comprehensive Bioinformatics Analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1483425
Original Research
Accepted on 18 Nov 2024
Adjuvant sorafenib for hepatocellular carcinoma after radiofrequency ablation versus radiofrequency ablation: analysis of its efficacy and safety Author Information
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1383312
Original Research
Accepted on 18 Nov 2024
Comprehensive Diagnostic and Therapeutic Approaches to Uterine Teratoma in Postmenopausal Women: A Case Study and Review
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1458187
Original Research
Accepted on 18 Nov 2024
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1433256
Original Research
Accepted on 18 Nov 2024
Comparative Analysis of the Clinical Aspects of Colorectal Cancer in Young Adult and Older Adult Patients in Saudi Arabia
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1460636
Original Research
Accepted on 18 Nov 2024
A Diagnostic Index for Predicting Heart Rate Variability Decline and Prognostic Value in Newly Diagnosed Non-Small Cell Lung Cancer Patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1463805
Original Research
Accepted on 18 Nov 2024
Total Retroperitoneal Lipectomy Improves Prognosis in Patients with Primary Retroperitoneal Liposarcoma: A Comparative Study
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1488143
Review
Accepted on 18 Nov 2024
Advances in the Application of Colorectal Cancer Organoids in Precision Medicine
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1506606
- 119 views